跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 213 条关于
“MDR3”
全部
213
临床试验
157
药物
44
机构
1
资讯
11
2年前
Maralixibat Demonstrates Efficacy in Treating Pruritus and Reducing Bile Acids in PFIC Patients
去年
ReShape Lifesciences Achieves Early EU MDR Certification for Obesity Treatment Devices
去年
Shattuck Labs Announces Key Milestones for SL-325 Program Targeting Inflammatory Diseases
去年
Shattuck Labs Prioritizes SL-325, a DR3 Antagonist, for Inflammatory Bowel Disease
去年
India's DTAB Recommends MDR Amendment to Include EU for Medical Device Approvals
去年
VUNO's AI-Powered Cardiac Arrest Prediction System Secures CE MDR and UKCA Certifications
去年
Paragonix Secures EU MDR Approval for Five Organ Preservation Devices, Expanding European Market Access
去年
Diamyd Immunotherapy Shows Robust Efficacy in Type 1 Diabetes Patients with HLA DR3-DQ2
去年
Diamyd Immunotherapy Shows Robust Efficacy in Type 1 Diabetes Patients with HLA DR3-DQ2
去年
Shattuck Labs Secures $103 Million to Advance First-in-Class DR3 Antibody SL-325 Through Phase 2 Trials
第 1 页,共 2 页
上一页
下一页